GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1993 | 06-1993 | 03-1993 | 12-1992 | 09-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,380 | 2,070 | 3,560 | 3,780 | 3,770 |
| Marketable Securities | 690 | 870 | 410 | N/A | 130 |
| Receivables | 920 | 20 | 8 | 750 | 460 |
| Inventories | 260 | 260 | 180 | 90 | 100 |
| Other current assets | 60 | 80 | 72 | 50 | 80 |
| TOTAL | $3,310 | $3,300 | $4,230 | $4,670 | $4,540 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,530 | $3,530 | $4,410 | $4,860 | $4,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $660 | $240 | $190 | $590 | $290 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $660 | $240 | $190 | $590 | $290 |
| Shareholders' Equity | |||||
| Common Shares | 15,350 | 15,350 | 15,350 | 15,350 | 15,350 |
| Retained earnings | -12,480 | -12,060 | -11,130 | -11,080 | -10,890 |
| Other shareholders' equity | -10 | 0 | 0 | -10 | -10 |
| TOTAL | $2,860 | $3,290 | $4,220 | $4,260 | $4,450 |
| Total Liabilities And Equity | $3,520 | $3,530 | $4,410 | $4,850 | $4,740 |